|
HECA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75541999999362E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.86990000051024E-07 |
| Normal-vs-Stage2 |
2.123900E-02 |
| Normal-vs-Stage3 |
6.044100E-02 |
| Normal-vs-Stage4 |
1.390210E-01 |
| Stage1-vs-Stage2 |
2.352600E-01 |
| Stage1-vs-Stage3 |
1.151800E-01 |
| Stage1-vs-Stage4 |
7.265600E-01 |
| Stage2-vs-Stage3 |
8.504200E-01 |
| Stage2-vs-Stage4 |
6.681400E-01 |
| Stage3-vs-Stage4 |
5.888600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82019999994676E-06 |
| Normal-vs-AfricanAmerican |
2.863400E-03 |
| Normal-vs-Asian |
6.30050000000049E-05 |
| Caucasian-vs-AfricanAmerican |
3.386000E-01 |
| Caucasian-vs-Asian |
1.154430E-01 |
| AfricanAmerican-vs-Asian |
9.465200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46879999995964E-06 |
| Normal-vs-Female |
1.943640E-02 |
| Male-vs-Female |
8.517900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.222400E-04 |
| Normal-vs-Extreme_Weight |
8.09480000030227E-07 |
| Normal-vs-Obese |
3.983100E-03 |
| Normal-vs-Extreme_Obese |
1.79609999995112E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.271400E-01 |
| Normal_Weight-vs-Obese |
4.384400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.565900E-02 |
| Extreme_Weight-vs-Obese |
5.655700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.262100E-02 |
| Obese-vs-Extreme_Obese |
3.822600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.906450E-01 |
| Normal-vs-Age(41-60Yrs) |
1.600880E-04 |
| Normal-vs-Age(61-80Yrs) |
2.61609999996359E-06 |
| Normal-vs-Age(81-100Yrs) |
9.96930000000118E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.996000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.338420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.818200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.327800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.387550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.854400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17899999999105E-06 |
| Normal-VS-Type2 PRCC |
4.82560000003573E-06 |
| Normal-VS-KIRP CIMP |
7.828300E-02 |
| Normal-VS-Unclassified PRCC |
1.077960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.645800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.77610999999578E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.010400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.155700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.991500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.362300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.68990000010739E-07 |
| Normal-vs-N1 |
4.893400E-01 |
| Normal-vs-N2 |
7.752200E-02 |
| N0-vs-N1 |
1.211630E-02 |
| N0-vs-N2 |
5.269800E-01 |
| N1-vs-N2 |
4.754200E-01 |
|
|
